Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer



Status:Recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:10/13/2018
Start Date:February 2014
End Date:December 2020
Contact:Nicole Winkler, MD
Email:nicole.winkler@hsc.utah.edu
Phone:801-587-4309

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Ultrasound Guided Core Needle Biopsy Versus Fine Needle Aspiration of Morphologically Abnormal Axillary Lymph Node in Patients With New Diagnosis or Suspected Diagnosis of Invasive Breast Carcinoma

To compare accuracy of ultrasound guided fine needle aspiration (FNA) to core needle biopsy
(CNB) of ultrasound detected abnormal axillary lymph nodes in patients with newly diagnosed
invasive breast cancer or suspected invasive breast cancer.

Hypothesis: FNA and CNB have equivalent diagnostic accuracies

In order to prove our hypothesis, we will perform FNA and CNB on the same lymph node in each
consented patient. The two samples will be evaluated separately by different pathologists
blinded to the material in the other sample.

The results of the biopsies will be compared to the gold standard (lymph node excision).


Inclusion Criteria:

- Recent or suspected diagnosis of invasive breast cancer with abnormal ipsilateral
axillary lymph node

- Able to provide informed consent

Exclusion Criteria:

- Lymph node not amenable to core biopsy

- Patient is unlikely to undergo lymph node excision (i.e. elderly patient with
co-morbidities)
We found this trial at
1
site
Huntsman Cancer Hospital
Salt Lake City, Utah 84112
Principal Investigator: Nicole Winkler, MD
Phone: 801-587-4602
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials